Windlas Biotech Ltd - 543329 - Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2021.
Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2021. Submitted voluntarily. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Conference Call to discuss financial performance for quarter ended June 30, 2021 Windlas Biotech Ltd - 543329 - Shareholding for the Period Ended August 11, 2021
Windlas Biotech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended August 11, 2021. For more details, kindly Click here Windlas Biotech Ltd - 543329 - Board Meeting Intimation for A Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Wednesday, The September 8, 2021, Inter Alia, To Consider And Approve The Unaudited Financial Results Of The Company For The First Quarter Ended June 30, 2021.
Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/09/2021 ,inter alia, to consider and approve To consider and approve the unaudited financial results of the Company for the first quarter ended June 30, 2021. Windlas Biotech Ltd - 543329 - Closure of Trading Window
Trading Window of the Company is already closed from August 25, 2021 and shall reopen on September 11, 2021. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Windlas Biotech hits new low since listing; falls 16% against issue price
The stock was trading lower for the third straight day since listing Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Windlas Biotech shares settle with 11.6% loss to issue price in debut trade
Cumulatively, Windlas Biotech traded with volume of 44.3 lakh equity shares on the BSE and NSE.